Mississippi SB 2561: Ibogaine; authorize MSDH to select a consortium to conduct a drug development clinical trial to secure FDA's approval of.

Status: Died In Committee (as of 2026-02-03)

State: Mississippi · Session: 2026 · Bill: SB 2561

Subjects: Public Health and Welfare

Sponsors: Harkins

View Mississippi SB 2561 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.